Abstract:OBJECTIVE:To assess the factors associated with initial incomplete ablation (ICA) after radiofrequency ablation for benign thyroid nodules (BTNs). MATERIALS AND METHODS:69 BTNs (mean volume 6.35±5.66 ml, range 1.00-25.04 ml) confirmed by fine-needle aspiration cytology (FNAC) in fifty-four patients were treated with ultrasound-guided percutaneous radiofrequency ablation (RFA) and the local treatment efficacy was immediately assessed by intra-procedural contrast-enhanced ultrasound (CEUS). The RFA was performed with a bipolar electrode (CelonProSurge 150-T20, output power: 20 W). CEUS was performed with a second generation contrast agent under low acoustic power (i.e. coded phase inversion, CPI). Characteristics of clinical factors, findings on conventional gray-scale ultrasound, color-Doppler ultrasound, and CEUS were evaluated preoperatively. Factors associated with initial ICA and initial ICA patterns on CEUS were assessed. Volume reduction ratios (VRRs) of ICA nodules were compared with those with complete ablation (CA). RESULTS:The RFA procedures were accomplished with a mean ablation time and mean total energy deposition of 11.13±3.39 min (range, 5.38-22.13 min) and 12612±4466 J (range, 6310-26130 J) respectively. CEUS detected initial ICA in 21 of 69 (30.8%) BTNs and 16 (76.2%) of the 21 BTNs with initial ICA achieved CA after additional RFA, leading to a final CA rate of 92.8% (64/69). The factors associated with initial ICA were predominantly solid nodule, nodule close to danger triangle area, nodule close to carotid artery, and peripheral blood flow on color-Doppler ultrasound (all P < 0.05). The mean VRRs of all BTNs were 23.4%, 54.4% and 81.9% at the 1-, 3- and 6-month follow-up, respectively. All BTNs achieved therapeutic success in this series in that all had VRRs of >50% at the 6-month follow-up, among which 7 nodules (10.1%) had VRRs of >90%. There were significant differences in VRRs between ICA nodules and CA nodules at the 3- and 6-month follow-up (all P < 0.05). CONCLUSION:The factors associated with initial ICA after RFA for BTNs were predominantly solid nodules, nodule close to danger triangle area, nodule close to carotid artery, and peripheral blood flow on color-Doppler ultrasound. CEUS assists quick treatment response evaluation and facilitates subsequent additional RFA and final CA of the nodules. Nodules with CA achieve a better outcome in terms of VRR in comparison with those with ICA.

Long-term follow-up of the radiofrequency ablation of benign thyroid nodules: the value of additional treatment

Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: 10-Year Experience

Vital Volume Increase Versus Clinical Evaluation As The Indication Of Additional Radiofrequency Ablation For Benign Thyroid Nodule: A Single Center Retrospective Study

A 6-year single-center prospective follow-up study of the efficacy of radiofrequency ablation for thyroid nodules

Long-Term Results of Thermal Ablation of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis

Early second radiofrequency ablation treatment gave rise to significantly greater nodule shrinkage at 12 months than single-session treatment for large-volume benign thyroid nodules

Radiofrequency ablation of Bethesda category III thyroid nodules with benign molecular testing: Preliminary findings from a single institution

Treatment Efficacy and Safety of Ultrasound-Guided Percutaneous Bipolar Radiofrequency Ablation for Benign Thyroid Nodules.

Patient Satisfaction of Radiofrequency Ablation for Symptomatic Benign Solid Thyroid Nodules: Our Experience for 2-Year Follow Up

Multicenter Study of Benign Thyroid Nodules with Radiofrequency Ablation: Results of 762 Cases over 4 Years in Taiwan

Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules.

Efficacy and Safety of Single-Session Radiofrequency Ablation in Treating Benign Thyroid Nodules: A Short-Term Prospective Cohort Study

Microwave Ablation of Benign Thyroid Nodules: 3-Year Follow-Up Outcomes

Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes

Factors Associated with Initial Incomplete Ablation for Benign Thyroid Nodules after Radiofrequency Ablation: First Results of CEUS Evaluation

Radiofrequency ablation for symptomatic, non-functioning, thyroid nodules: a single-center learning curve

Efficacy and safety of radiofrequency ablation for calcified benign thyroid nodules: results of over 5 years' follow-up

Long-Term Results of Ultrasound-Guided Radiofrequency Ablation of Benign Thyroid Nodules: State of the Art and Future Perspectives—A Systematic Review

Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules: A Multicenter Study

Significance of radiofrequency ablation in large solid benign thyroid nodules

Radiofrequency Ablation for Treatment of Benign Thyroid Nodules